Ha habido 50 transacciones internas recientes registradas para Sotera Health Company (SHC), incluyendo 20 compras y 25 ventas. El total de compras internas fue valorado en RSU Award y el total de ventas internas en $1.8B.
Internos destacados con actividad reciente incluyen Dimitrief Alexander, Krause Kenneth D., Warburg Pincus & Co.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — SHC
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-31 |
Dimitrief Alexander |
Former SVP, Gc and Sec. |
Retención Fiscal de RSU |
7,941 |
$14.34 |
$113.87K |
312,040 |
| 2026-03-16 |
Krause Kenneth D. |
Officer |
Desconocido |
- |
- |
- |
- |
| 2026-03-06 |
Warburg Pincus & Co. |
10 Percent Owner |
Venta Informativa |
15,000,000 |
$15.27 |
$229.05M |
19,102,952 |
| 2026-03-06 |
Gtcr Investment Xi Llc |
10 Percent Owner |
Venta Informativa |
10,000,000 |
$15.27 |
$152.7M |
12,735,301 |
| 2026-03-02 |
Rutz Michael P |
President of Sterigenics |
Ejercicio de Opciones (Venta) |
14,573 |
- |
- |
9,716 |
| 2026-03-02 |
Dimitrief Alexander |
SVP, General Counsel and Sec. |
Ejercicio de Opciones (Venta) |
16,816 |
- |
- |
11,210 |
| 2026-03-02 |
Petras Michael B. Jr. |
Chairman & CEO |
Ejercicio de Opciones (Venta) |
89,686 |
- |
- |
59,790 |
| 2026-03-02 |
Lyons Jonathan M. |
Sr. Vice President, CFO |
Ejercicio de Opciones (Venta) |
17,937 |
- |
- |
11,958 |
| 2026-02-04 |
Kyle Richard G |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-12-08 |
Petras Michael B. Jr. |
Chairman & CEO |
Venta Informativa |
39,243 |
$16.45 |
$645.55K |
- |
| 2025-12-03 |
Warburg Pincus & Co. |
10 Percent Owner |
Venta Informativa |
9,720,000 |
$16.33 |
$158.73M |
34,102,952 |
| 2025-12-03 |
Gtcr Investment Xi Llc |
10 Percent Owner |
Venta Informativa |
6,480,000 |
$16.33 |
$105.82M |
22,735,301 |
| 2025-11-10 |
Warburg Pincus & Co. |
10 Percent Owner |
Venta Informativa |
18,000,000 |
$15.65 |
$281.72M |
43,822,952 |
| 2025-11-10 |
Gtcr Investment Xi Llc |
10 Percent Owner |
Venta Informativa |
12,000,000 |
$15.65 |
$187.81M |
29,215,301 |
| 2025-09-05 |
Warburg Pincus & Co. |
10 Percent Owner |
Venta Informativa |
12,000,000 |
$15.11 |
$181.33M |
61,822,952 |
| 2025-09-05 |
Gtcr Investment Xi Llc |
10 Percent Owner |
Venta Informativa |
8,000,000 |
$15.11 |
$120.89M |
41,215,301 |
| 2025-08-22 |
Rutz Michael P |
President of Sterigenics |
Venta Informativa |
126,611 |
$16.38 |
$2.07M |
450,204 |
| 2025-08-05 |
Lyons Jonathan M. |
Sr. Vice President, CFO |
Retención Fiscal de RSU |
11,508 |
$11.19 |
$128.77K |
189,602 |
| 2025-05-22 |
Mihas Constantine S |
Director |
Concesión de RSU |
19,132 |
- |
- |
80,781 |
| 2025-05-22 |
Petrella Vincent K |
Director |
Concesión de RSU |
19,132 |
- |
- |
80,781 |
| 2025-05-22 |
Neary James |
Director |
Concesión de RSU |
19,132 |
- |
- |
80,781 |
| 2025-05-22 |
Flynn Karen |
Director |
Concesión de RSU |
19,132 |
- |
- |
39,221 |
| 2025-05-22 |
Simon, Christopher |
Director |
Concesión de RSU |
19,132 |
- |
- |
19,132 |
| 2025-05-22 |
Chen Ruoxi |
Director |
Concesión de RSU |
19,132 |
- |
- |
80,781 |
| 2025-05-22 |
Wheadon David E. |
Director |
Concesión de RSU |
19,132 |
- |
- |
74,912 |
| 2025-05-22 |
Klee Ann R. |
Director |
Concesión de RSU |
19,132 |
- |
- |
125,956 |
| 2025-05-22 |
Cunningham Sean Laurence |
Director |
Concesión de RSU |
19,132 |
- |
- |
80,781 |
| 2025-05-22 |
Knauss Robert Brown |
Director |
Concesión de RSU |
19,132 |
- |
- |
54,933 |
| 2025-03-03 |
Rutz Michael P |
President of Sterigenics |
Concesión de RSU |
24,289 |
- |
- |
24,289 |
| 2025-03-03 |
Dimitrief Alexander |
SVP, General Counsel and Sec. |
Concesión de RSU |
28,026 |
- |
- |
28,026 |
| 2025-03-03 |
Petras Michael B. Jr. |
Chairman & CEO |
Concesión de RSU |
149,476 |
- |
- |
149,476 |
| 2025-03-03 |
Lyons Jonathan M. |
Sr. Vice President, CFO |
Concesión de RSU |
29,895 |
- |
- |
29,895 |
| 2025-03-02 |
Rutz Michael P |
President of Sterigenics |
Retención Fiscal de RSU |
5,399 |
$12.47 |
$67.33K |
528,236 |
| 2025-03-02 |
Dimitrief Alexander |
SVP, General Counsel and Sec. |
Retención Fiscal de RSU |
8,211 |
$12.47 |
$102.39K |
278,672 |
| 2025-03-02 |
Petras Michael B. Jr. |
Chairman & CEO |
Retención Fiscal de RSU |
40,987 |
$12.47 |
$511.11K |
569,650 |
| 2025-03-02 |
Lyons Jonathan M. |
Sr. Vice President, CFO |
Retención Fiscal de RSU |
6,481 |
$12.47 |
$80.82K |
103,951 |
| 2024-11-22 |
Petras Michael B. Jr. |
Chairman & CEO |
Donación (Recibida) |
39,243 |
- |
- |
39,243 |
| 2024-11-20 |
Rutz Michael P |
President of Sterigenics |
Retención Fiscal de RSU |
2,889 |
$13.21 |
$38.16K |
541,520 |
| 2024-11-20 |
Petras Michael B. Jr. |
Chairman & CEO |
Retención Fiscal de RSU |
29,250 |
$13.21 |
$386.39K |
670,499 |
| 2024-09-10 |
Petras Michael B. Jr. |
Chairman & CEO |
Donación (Otorgada) |
200,000 |
- |
- |
5,253,580 |
| 2024-09-06 |
Warburg Pincus & Co. |
10 Percent Owner |
Venta Informativa |
15,000,000 |
$15.03 |
$225.45M |
73,822,952 |
| 2024-09-06 |
Gtcr Investment Xi Llc |
10 Percent Owner |
Venta Informativa |
10,000,000 |
$15.03 |
$150.3M |
49,215,301 |
| 2024-08-05 |
Lyons Jonathan M. |
Sr. Vice President, CFO |
Retención Fiscal de RSU |
7,659 |
$14.22 |
$108.91K |
110,432 |
| 2024-08-01 |
Simon, Christopher |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-05-24 |
Mihas Constantine S |
Director |
Concesión de RSU |
20,089 |
- |
- |
61,649 |
| 2024-05-24 |
Petrella Vincent K |
Director |
Concesión de RSU |
20,089 |
- |
- |
61,649 |
| 2024-05-24 |
Donnini David |
Director |
Concesión de RSU |
20,089 |
- |
- |
61,649 |
| 2024-05-24 |
Neary James |
Director |
Concesión de RSU |
20,089 |
- |
- |
61,649 |
| 2024-05-24 |
Flynn Karen |
Director |
Concesión de RSU |
20,089 |
- |
- |
20,089 |
| 2024-05-24 |
Chen Ruoxi |
Director |
Concesión de RSU |
20,089 |
- |
- |
61,649 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
